These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30324422)

  • 1. Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.
    Cheeti S; Hou HH; Nelson E; Walker H; Chen B; Morley R; Gates M; Musib L; Girish S; Sahasranaman S; Liu L
    Pharm Res; 2018 Oct; 35(12):233. PubMed ID: 30324422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Microenvironmental pH Modulation on the Dissolution Rate and Oral Absorption of the Salt of a Weak Acid - Case Study of GDC-0810.
    Hou HH; Jia W; Liu L; Cheeti S; Li J; Nauka E; Nagapudi K
    Pharm Res; 2018 Jan; 35(2):37. PubMed ID: 29380076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDC-0810 Pharmacokinetics and Transporter-Mediated Drug Interaction Evaluation with an Endogenous Biomarker in the First-in-Human, Dose Escalation Study.
    Cheung KWK; Yoshida K; Cheeti S; Chen B; Morley R; Chan IT; Sahasranaman S; Liu L
    Drug Metab Dispos; 2019 Sep; 47(9):966-973. PubMed ID: 31266752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
    Ware JA; Dalziel G; Jin JY; Pellett JD; Smelick GS; West DA; Salphati L; Ding X; Sutton R; Fridyland J; Dresser MJ; Morrisson G; Holden SN
    Mol Pharm; 2013 Nov; 10(11):4074-81. PubMed ID: 24099279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using pH Gradient Dissolution with In-Situ Flux Measurement to Evaluate Bioavailability and DDI for Formulated Poorly Soluble Drug Products.
    Li J; Tsinman K; Tsinman O; Wigman L
    AAPS PharmSciTech; 2018 Oct; 19(7):2898-2907. PubMed ID: 30209787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the hardness of dry granulated tablets containing sodium lauryl sulfate.
    Moore F; Okelo G; Colón I; Kushner J
    Int J Pharm; 2010 Nov; 400(1-2):37-41. PubMed ID: 20801204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the Wetting Agent Sodium Lauryl Sulfate on the Pharmacokinetics of Alectinib: Results From a Bioequivalence Study in Healthy Subjects.
    Morcos PN; Parrott N; Banken L; Timpe C; Lindenberg M; Guerini E; Dall G; Bogman K; Sturm C; Zeaiter A; Martin-Facklam M; Phipps A
    Clin Pharmacol Drug Dev; 2017 May; 6(3):266-279. PubMed ID: 27545871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
    Rajpoot P; Bali V; Pathak K
    Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats.
    Wu L; Qiao Y; Wang L; Guo J; Wang G; He W; Yin L; Zhao J
    AAPS PharmSciTech; 2015 Oct; 16(5):1051-8. PubMed ID: 25652729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.
    Joseph JD; Darimont B; Zhou W; Arrazate A; Young A; Ingalla E; Walter K; Blake RA; Nonomiya J; Guan Z; Kategaya L; Govek SP; Lai AG; Kahraman M; Brigham D; Sensintaffar J; Lu N; Shao G; Qian J; Grillot K; Moon M; Prudente R; Bischoff E; Lee KJ; Bonnefous C; Douglas KL; Julien JD; Nagasawa JY; Aparicio A; Kaufman J; Haley B; Giltnane JM; Wertz IE; Lackner MR; Nannini MA; Sampath D; Schwarz L; Manning HC; Tantawy MN; Arteaga CL; Heyman RA; Rix PJ; Friedman L; Smith ND; Metcalfe C; Hager JH
    Elife; 2016 Jul; 5():. PubMed ID: 27410477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).
    Moes JJ; Koolen SL; Huitema AD; Schellens JH; Beijnen JH; Nuijen B
    Int J Pharm; 2011 Nov; 420(2):244-50. PubMed ID: 21907780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
    Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.
    O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT
    Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Oral Bioavailability of Sorafenib by Optimizing the "Spring" and "Parachute" Based on Molecular Interaction Mechanisms.
    Liu C; Chen Z; Chen Y; Lu J; Li Y; Wang S; Wu G; Qian F
    Mol Pharm; 2016 Feb; 13(2):599-608. PubMed ID: 26709621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and optimizing the dual excipient functionality of sodium lauryl sulfate in tablet formulation of poorly water soluble drug: wetting and lubrication.
    Aljaberi A; Chatterji A; Dong Z; Shah NH; Malick W; Singhal D; Sandhu HK
    Pharm Dev Technol; 2013; 18(2):490-503. PubMed ID: 23009028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Lauryl Sulfate Salts: Prevalence, Formation Rules, and Formulation Implications.
    Guo Y; Sun CC
    Mol Pharm; 2022 Feb; 19(2):432-439. PubMed ID: 34672628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of
    Mulder T; Bobba S; Johnson K; Grandner JM; Wang W; Zhang C; Cai J; Choo EF; Khojasteh SC; Zhang D
    Drug Metab Dispos; 2020 Sep; 48(9):819-829. PubMed ID: 32616543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole.
    Dave RH; Patel HH; Donahue E; Patel AD
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1562-72. PubMed ID: 23030270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Selective Estrogen Receptor Degrader GDC-0810 via Stereocontrolled Assembly of a Tetrasubstituted All-Carbon Olefin.
    Savage S; McClory A; Zhang H; Cravillion T; Lim NK; Masui C; Robinson SJ; Han C; Ochs C; Rege PD; Gosselin F
    J Org Chem; 2018 Oct; 83(19):11571-11576. PubMed ID: 30200756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.